Skip to main content
. 2023 Aug 23;13(8):e071148. doi: 10.1136/bmjopen-2022-071148

Table 1.

A summary of assessments completed throughout the investigation

Measure (ordered first to last) Screening Treatment session 1–3
At-home sleep monitoring Night Day
Informed consent ·
Medical examination · ·
Baseline questionnaires (ISI, ESS, HADS and PHQ-9) ·
ECG ·
Urinary drug and alcohol screen · ·
Pregnancy test · ·
Overnight polysomnography (clinical EEG) · ·
Actigraphy ·
Sleep diary (KSD) ·
Oral fluid drug screen (Securetech DrugWipe) · ·
Quantisal saliva collection · ·
Blood plasma collection · ·
Urine collection · ·
Mood (POMS) · ·
Drug effects (DEQ) · ·
Balance (posturography) · ·
Memory (FTT and WPT) · ·
KDT with EEG · ·
Sleep questionnaires (LSEQ, RCSQ and KSS) ·
Simulated driving performance ·
PVT ·

DEQ, Drug Effects Questionnaire; ECG, electrocardiogram; EEG, electroencephalography; ESS, Epworth Sleepiness Scale; FTT, Finger Tapping Task; HADS, Hospital Anxiety Depression Scale; ISI, Insomnia Severity Index; KDT, Karolinska Drowsiness Test; KSD, Karolinska Sleep Diary; KSS, Karolinska Sleepiness Scale; LSEQ, Leeds Sleep Evaluation Questionnaire; PHQ-9, Patient Health Questionnaire-9; POMS, Profile of Mood States; PSG, polysomnography; PVT, Psychomotor Vigilance Task; RCSQ, Richard Campbell Sleep Questionnaire; WPT, Word Pairs Task.